{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:30:29Z","timestamp":1791822629772,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T00:00:00Z","timestamp":1523836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s10067-018-4095-1","type":"journal-article","created":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T03:34:01Z","timestamp":1523849641000},"page":"3329-3335","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":110,"title":["Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature"],"prefix":"10.1007","volume":"37","author":[{"given":"Hafize Emine","family":"S\u00f6nmez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selcan","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelda","family":"Bilginer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seza","family":"\u00d6zen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,16]]},"reference":[{"key":"4095_CR1","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/ped.13064","volume":"58","author":"A Morimoto","year":"2016","unstructured":"Morimoto A, Nakazawa Y, Ishii E (2016) Hemophagocytic lymphohistiocytosis: pathogenesis, diagnosis, and management. Pediatr Int Off J Jpn Pediatr Soc 58:817\u2013825","journal-title":"Pediatr Int Off J Jpn Pediatr Soc"},{"key":"4095_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/bjh.14144","volume":"174","author":"E Brisse","year":"2016","unstructured":"Brisse E, Matthys P, Wouters CH (2016) Understanding the spectrum of haemophagocytic lymphohistiocytosis: update on diagnostic challenges and therapeutic options. Br J Haematol 174:175\u2013187","journal-title":"Br J Haematol"},{"key":"4095_CR3","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s00296-016-3545-9","volume":"36","author":"S Aytac","year":"2016","unstructured":"Aytac S, Batu ED, Unal S et al (2016) Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus. Rheumatol Int 36:1421\u20131429","journal-title":"Rheumatol Int"},{"key":"4095_CR4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3389\/fphar.2016.00467","volume":"7","author":"G Giancane","year":"2016","unstructured":"Giancane G, Minoia F, Davi S et al (2016) IL-1 inhibition in systemic juvenile idiopathic arthritis. Front Pharmacol 7:467","journal-title":"Front Pharmacol"},{"key":"4095_CR5","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/acr.23120","volume":"69","author":"S Ozen","year":"2017","unstructured":"Ozen S, Kuemmerle-Deschner JB, Cimaz R, Livneh A, Quartier P, Kone-Paut I, Zeft A, Spalding S, Gul A, Hentgen V, Savic S, Foeldvari I, Frenkel J, Cantarini L, Patel D, Weiss J, Marinsek N, Degun R, Lomax KG, Lachmann HJ (2017) International retrospective chart review of treatment patterns in severe familial mediterranean fever, tumor necrosis factor receptor-associated periodic syndrome, and mevalonate kinase deficiency\/hyperimmunoglobulinemia D syndrome. Arthritis Care Res 69:578\u2013586","journal-title":"Arthritis Care Res"},{"issue":"4","key":"4095_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/RHU.0b013e3181a4f459","volume":"15","author":"A Zeft","year":"2009","unstructured":"Zeft A, Hollister R, LaFleur B, Sampath P, Soep J, McNally B, Kunkel G, Schlesinger M, Bohnsack J (2009) Anakinra for systemic juvenile arthritis: the Rocky Mountain experience. J Clin Rheumatol 15(4):161\u2013164","journal-title":"J Clin Rheumatol"},{"key":"4095_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/RHU.0b013e318205092d","volume":"17","author":"N Bruck","year":"2011","unstructured":"Bruck N, Suttorp M, Kabus M, Heubner G, Gahr M, Pessler F (2011) Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids. J Clin Rheumatol 17:23\u201327","journal-title":"J Clin Rheumatol"},{"key":"4095_CR8","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s10067-015-2923-0","volume":"34","author":"D Rigante","year":"2015","unstructured":"Rigante D, Emmi G, Fastiggi M, Silvestri E, Cantarini L (2015) Macrophage activation syndrome in the course of monogenic autoinflammatory disorders. Clin Rheumatol 34:1333\u20131339","journal-title":"Clin Rheumatol"},{"key":"4095_CR9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/annrheumdis-2015-208982","volume":"75","author":"A Ravelli","year":"2016","unstructured":"Ravelli A, Minoia F, Davi S et al (2016) Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European league against rheumatism\/American College of Rheumatology\/Paediatric rheumatology international trials organisation collaborative initiative. Annals Rheum Dis 75:481\u2013489","journal-title":"Annals Rheum Dis"},{"key":"4095_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Arico M et al (2007) HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48:124\u2013131","journal-title":"Pediatr Blood Cancer"},{"key":"4095_CR11","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jpeds.2017.06.005","volume":"189","author":"F Minoia","year":"2017","unstructured":"Minoia F, Bovis F, Davi S et al (2017) Development and initial validation of the macrophage activation syndrome\/primary hemophagocytic lymphohistiocytosis score, a diagnostic tool that differentiates primary Hemophagocytic lymphohistiocytosis from macrophage activation syndrome. J Pediatr 189:72\u201378.e3","journal-title":"J Pediatr"},{"key":"4095_CR12","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/ncprheum0919","volume":"4","author":"A Kelly","year":"2008","unstructured":"Kelly A, Ramanan AV (2008) A case of macrophage activation syndrome successfully treated with anakinra. Nat Clin Pract Rheumatol 4:615\u2013620","journal-title":"Nat Clin Pract Rheumatol"},{"key":"4095_CR13","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3899\/jrheum.121098","volume":"40","author":"PJ Kahn","year":"2013","unstructured":"Kahn PJ, Cron RQ (2013) Higher-dose Anakinra is effective in a case of medically refractory macrophage activation syndrome. J Rheumatol 40:743\u2013744","journal-title":"J Rheumatol"},{"key":"4095_CR14","doi-asserted-by":"publisher","first-page":"206","DOI":"10.5152\/TurkPediatriArs.2015.3299","volume":"50","author":"K Barut","year":"2015","unstructured":"Barut K, Yucel G, Sinoplu AB, Sahin S, Adrovic A, Kasapcopur O (2015) Evaluation of macrophage activation syndrome associated with systemic juvenile idiopathic arthritis: single center experience over a one-year period. Turk Pediatri Arsivi 50:206\u2013210","journal-title":"Turk Pediatri Arsivi"},{"key":"4095_CR15","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/rheumatology\/keq218","volume":"50","author":"PM Miettunen","year":"2011","unstructured":"Miettunen PM, Narendran A, Jayanthan A, Behrens EM, Cron RQ (2011) Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients. Rheumatology 50:417\u2013419","journal-title":"Rheumatology"},{"key":"4095_CR16","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3109\/03009742.2015.1033009","volume":"44","author":"M Marsili","year":"2015","unstructured":"Marsili M, Nozzi M, Onofrillo D, Sieni E, Chiarelli F, Breda L (2015) Kikuchi disease, macrophage activation syndrome, and systemic juvenile arthritis: a new case associated with a mutation in the perforin gene. Scand J Rheumatol 44:429\u2013430","journal-title":"Scand J Rheumatol"},{"key":"4095_CR17","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/art.38345","volume":"66","author":"V Mohr","year":"2014","unstructured":"Mohr V, Schulz A, Lohse P, Schumann C, Debatin KM, Schuetz C (2014) Urticaria, fever, and hypofibrinogenemia. Arthritis Rheumatol 66:1377","journal-title":"Arthritis Rheumatol"},{"key":"4095_CR18","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1002\/acr.22527","volume":"67","author":"GS Schulert","year":"2015","unstructured":"Schulert GS, Bove K, McMasters R, Campbell K, Leslie N, Grom AA (2015) 11-month-old infant with periodic fevers, recurrent liver dysfunction, and perforin gene polymorphism. Arthritis Care Res 67:1173\u20131179","journal-title":"Arthritis Care Res"},{"key":"4095_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12969-015-0055-3","volume":"13","author":"V Boom","year":"2015","unstructured":"Boom V, Anton J, Lahdenne P, Quartier P, Ravelli A, Wulffraat NM, Vastert SJ (2015) Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Pediatr Rheumatol Online J 13:55","journal-title":"Pediatr Rheumatol Online J"},{"key":"4095_CR20","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0022-3476(96)70160-9","volume":"129","author":"R Mouy","year":"1996","unstructured":"Mouy R, Stephan JL, Pillet P, Haddad E, Hubert P, Prieur AM (1996) Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases. J Pediatr 129:750\u2013754","journal-title":"J Pediatr"},{"key":"4095_CR21","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00296-010-1711-z","volume":"32","author":"S Singh","year":"2012","unstructured":"Singh S, Chandrakasan S, Ahluwalia J, Suri D, Rawat A, Ahmed N, Das R, Sachdeva MUS, Varma N (2012) Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: clinical experience from northwest India. Rheumatol Int 32:881\u2013886","journal-title":"Rheumatol Int"},{"key":"4095_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/01.rhu.0000081259.61370.eb","volume":"9","author":"AG Tristano","year":"2003","unstructured":"Tristano AG, Casanova-Escalona L, Torres A, Rodr\u00edguez MA (2003) Macrophage activation syndrome in a patient with systemic onset rheumatoid arthritis: rescue with intravenous immunoglobulin therapy. J Clin Rheumatol 9:253\u2013258","journal-title":"J Clin Rheumatol"},{"key":"4095_CR23","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1002\/art.38802","volume":"66","author":"F Minoia","year":"2014","unstructured":"Minoia F, Davi S, Horne A et al (2014) Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Arthritis Rheumatol 66:3160\u20133169","journal-title":"Arthritis Rheumatol"},{"key":"4095_CR24","first-page":"1133","volume":"34","author":"EM Behrens","year":"2007","unstructured":"Behrens EM, Beukelman T, Paessler M, Cron RQ (2007) Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol 34:1133\u20131138","journal-title":"J Rheumatol"},{"key":"4095_CR25","first-page":"111","volume":"29","author":"E Demirkaya","year":"2011","unstructured":"Demirkaya E, Ozen S, Bilginer Y, Ayaz NA, Makay BB, Unsal E, Erguven M, Poyrazoglu H, Kasapcopur O, Gok F, Akman S, Balat A, Cavkaytar O, Kaya B, Duzova A, Ozaltin F, Topaloglu R, Besbas N, Bakkaloglu A, Arisoy N, Ozdogan H, Bakkaloglu S, Turker T (2011) The distribution of juvenile idiopathic arthritis in the eastern Mediterranean: results from the registry of the Turkish Paediatric Rheumatology Association. Clin Exp Rheumatol 29:111\u2013116","journal-title":"Clin Exp Rheumatol"},{"key":"4095_CR26","doi-asserted-by":"publisher","first-page":"e205","DOI":"10.1097\/MPH.0b013e31827b4859","volume":"35","author":"S Unal","year":"2013","unstructured":"Unal S, Balta G, Okur H, Aytac S, Cetin M, Gumruk F, Ozen S, Gurgey A (2013) Recurrent macrophage activation syndrome associated with heterozygous perforin W374X gene mutation in a child with systemic juvenile idiopathic arthritis. J Pediatr Hematol Oncol 35:e205\u2013e208","journal-title":"J Pediatr Hematol Oncol"},{"key":"4095_CR27","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1136\/ard.2003.016014","volume":"63","author":"SB Cohen","year":"2004","unstructured":"Cohen SB, Moreland LW, Cush JJ, Greenwald MW, Block S, Shergy WJ, Hanrahan PS, Kraishi MM, Patel A, Sun G, Bear MB, 990145 Study Group (2004) A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate. Ann Rheum Dis 63:1062\u20131068","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-018-4095-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4095-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4095-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T23:34:19Z","timestamp":1555371259000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-018-4095-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,16]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4095"],"URL":"https:\/\/doi.org\/10.1007\/s10067-018-4095-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,16]]},"assertion":[{"value":"12 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}